Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis A vaccination: a sensible luxury?]

R B Holzer1

  • 1Medizinische Universitäts-Poliklinik, Inselspital, Bern.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|February 16, 1993
PubMed
Summary

Travelers can now get vaccinated against hepatitis A, an effective alternative to immunoglobulins. While safe and beneficial, general hygiene remains the top priority for preventing this benign illness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Protection against biting mosquitoes].

Therapeutische Umschau. Revue therapeutique·2001
Same author

[Chronic abdominal pain and eosinophilia in a patient from Southern Italy].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1993
Same author

[A case from practice (263). Giardia lamblia infection of the intestines].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1993
Same author

[Malaria prevention without drugs].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1993
Same author

[Malaria prophylaxis: what is safe?].

Therapeutische Umschau. Revue therapeutique·1990
Same author

[Is it a tropical disease? What should the practicing physician know?].

Therapeutische Umschau. Revue therapeutique·1985

Area of Science:

  • Tropical medicine
  • Vaccinology
  • Public health

Context:

  • Hepatitis A prevention for travelers has historically relied on passive immunoglobulin administration.
  • A new, effective killed vaccine for hepatitis A became available in February 1992.
  • The vaccine targets the same high-risk groups as immunoglobulins, including long-term residents and backpackers.

Purpose:

  • To introduce the availability and indications of a new active killed hepatitis A vaccine.
  • To compare the new vaccine with previous passive immunization methods.
  • To discuss the potential for broader vaccine recommendations due to its efficacy and tolerability.

Summary:

  • An effective active killed hepatitis A vaccine is available, offering an alternative to immunoglobulin therapy for travelers.
  • The vaccine is indicated for long-term residents and backpackers, similar to immunoglobulin use.
  • The vaccine is effective, well-tolerated, and may allow for more liberal usage recommendations.

Impact:

  • The introduction of an active vaccine provides a more convenient and potentially longer-lasting protection against hepatitis A for travelers.
  • While the vaccine is a valuable tool, it does not replace the importance of fundamental hygienic practices for disease prevention.
  • The availability of an effective vaccine may influence public health strategies for managing hepatitis A in travel medicine.

Related Experiment Videos